866-997-4948(US-Canada Toll Free)

United States Fc Protein and Glycoengineered Antibodies Market Report 2017

Published By :

QYResearch

Published Date : Feb 2017

Category :

Pharmaceutical

No. of Pages : 99 Pages

Notes:
Sales, means the sales volume of Fc Protein and Glycoengineered Antibodies
Revenue, means the sales value of Fc Protein and Glycoengineered Antibodies

This report studies sales (consumption) of Fc Protein and Glycoengineered Antibodies in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Roche
TG Therapeutics
MedImmune/AstraZeneca
LFB Biotechnologies
Glycotope
Mentrik Biotech
MacroGenics
MorphoSys

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Fc Protein and Glycoengineered Antibodies in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Fc Protein and Glycoengineered Antibodies Market Report 2017
1 Fc Protein and Glycoengineered Antibodies Overview
1.1 Product Overview and Scope of Fc Protein and Glycoengineered Antibodies
1.2 Classification of Fc Protein and Glycoengineered Antibodies
1.2.1 Type I
1.2.2 Type II
1.3 Application of Fc Protein and Glycoengineered Antibodies
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Fc Protein and Glycoengineered Antibodies (2012-2022)
1.4.1 United States Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2012-2022)
1.4.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2012-2022)

2 United States Fc Protein and Glycoengineered Antibodies Competition by Manufacturers
2.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Fc Protein and Glycoengineered Antibodies Average Price by Manufactures (2015 and 2016)
2.4 Fc Protein and Glycoengineered Antibodies Market Competitive Situation and Trends
2.4.1 Fc Protein and Glycoengineered Antibodies Market Concentration Rate
2.4.2 Fc Protein and Glycoengineered Antibodies Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Fc Protein and Glycoengineered Antibodies Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share by States (2012-2017)
3.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by States (2012-2017)
3.3 United States Fc Protein and Glycoengineered Antibodies Price by States (2012-2017)

4 United States Fc Protein and Glycoengineered Antibodies Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share by Type (2012-2017)
4.2 United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2012-2017)
4.3 United States Fc Protein and Glycoengineered Antibodies Price by Type (2012-2017)
4.4 United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Type (2012-2017)

5 United States Fc Protein and Glycoengineered Antibodies Sales (Volume) by Application (2012-2017)
5.1 United States Fc Protein and Glycoengineered Antibodies Sales and Market Share by Application (2012-2017)
5.2 United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Fc Protein and Glycoengineered Antibodies Manufacturers Profiles/Analysis
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 TG Therapeutics
6.2.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 MedImmune/AstraZeneca
6.3.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 LFB Biotechnologies
6.4.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Glycotope
6.5.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Mentrik Biotech
6.6.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 MacroGenics
6.7.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 MorphoSys
6.8.2 Fc Protein and Glycoengineered Antibodies Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview

7 Fc Protein and Glycoengineered Antibodies Manufacturing Cost Analysis
7.1 Fc Protein and Glycoengineered Antibodies Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Fc Protein and Glycoengineered Antibodies Market Forecast (2017-2022)
11.1 United States Fc Protein and Glycoengineered Antibodies Sales, Revenue Forecast (2017-2022)
11.2 United States Fc Protein and Glycoengineered Antibodies Sales Forecast by Type (2017-2022)
11.3 United States Fc Protein and Glycoengineered Antibodies Sales Forecast by Application (2017-2022)
11.4 Fc Protein and Glycoengineered Antibodies Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Table

List of Tables and Figures

Figure Picture of Fc Protein and Glycoengineered Antibodies
Table Classification of Fc Protein and Glycoengineered Antibodies
Figure United States Sales Market Share of Fc Protein and Glycoengineered Antibodies by Type in 2015
Table Application of Fc Protein and Glycoengineered Antibodies
Figure United States Sales Market Share of Fc Protein and Glycoengineered Antibodies by Application in 2015
Figure United States Fc Protein and Glycoengineered Antibodies Sales and Growth Rate (2012-2022)
Figure United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate (2012-2022)
Table United States Fc Protein and Glycoengineered Antibodies Sales of Key Manufacturers (2015 and 2016)
Table United States Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers
Figure 2016 Fc Protein and Glycoengineered Antibodies Sales Share by Manufacturers
Table United States Fc Protein and Glycoengineered Antibodies Revenue by Manufacturers (2015 and 2016)
Table United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table 2016 United States Fc Protein and Glycoengineered Antibodies Revenue Share by Manufacturers
Table United States Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Fc Protein and Glycoengineered Antibodies Average Price of Key Manufacturers in 2015
Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 3 Manufacturers
Figure Fc Protein and Glycoengineered Antibodies Market Share of Top 5 Manufacturers
Table United States Fc Protein and Glycoengineered Antibodies Sales by States (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Sales Share by States (2012-2017)
Figure United States Fc Protein and Glycoengineered Antibodies Sales Market Share by States in 2015
Table United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by States (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Revenue Share by States (2012-2017)
Figure Revenue Market Share of Fc Protein and Glycoengineered Antibodies by States (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Price by States (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Sales by Type (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Sales Share by Type (2012-2017)
Figure United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Type in 2015
Table United States Fc Protein and Glycoengineered Antibodies Revenue and Market Share by Type (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Fc Protein and Glycoengineered Antibodies by Type (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Price by Type (2012-2017)
Figure United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Type (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Sales by Application (2012-2017)
Table United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Application (2012-2017)
Figure United States Fc Protein and Glycoengineered Antibodies Sales Market Share by Application in 2015
Table United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2012-2017)
Figure United States Fc Protein and Glycoengineered Antibodies Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table TG Therapeutics Basic Information List
Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table TG Therapeutics Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table MedImmune/AstraZeneca Basic Information List
Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune/AstraZeneca Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table LFB Biotechnologies Basic Information List
Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table LFB Biotechnologies Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table Glycotope Basic Information List
Table Glycotope Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Glycotope Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table Mentrik Biotech Basic Information List
Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mentrik Biotech Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table MacroGenics Basic Information List
Table MacroGenics Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table MacroGenics Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table MorphoSys Basic Information List
Table MorphoSys Fc Protein and Glycoengineered Antibodies Sales, Revenue, Price and Gross Margin (2012-2017)
Table MorphoSys Fc Protein and Glycoengineered Antibodies Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Fc Protein and Glycoengineered Antibodies
Figure Manufacturing Process Analysis of Fc Protein and Glycoengineered Antibodies
Figure Fc Protein and Glycoengineered Antibodies Industrial Chain Analysis
Table Raw Materials Sources of Fc Protein and Glycoengineered Antibodies Major Manufacturers in 2015
Table Major Buyers of Fc Protein and Glycoengineered Antibodies
Table Distributors/Traders List
Figure United States Fc Protein and Glycoengineered Antibodies Production and Growth Rate Forecast (2017-2022)
Figure United States Fc Protein and Glycoengineered Antibodies Revenue and Growth Rate Forecast (2017-2022)
Table United States Fc Protein and Glycoengineered Antibodies Production Forecast by Type (2017-2022)
Table United States Fc Protein and Glycoengineered Antibodies Consumption Forecast by Application (2017-2022)
Table United States Fc Protein and Glycoengineered Antibodies Sales Forecast by States (2017-2022)
Table United States Fc Protein and Glycoengineered Antibodies Sales Share Forecast by States (2017-2022)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *